REGULATED PRESS RELEASE published on 12/04/2025 at 07:01, 2 months ago bioMérieux lance deux tests pour l’endocrinologie équine : une avancée majeure pour le diagnostic et le suivi de maladies fréquentes chez les équidés bioMérieux lance deux tests pour l’endocrinologie équine, offrant des résultats précis en quelques minutes. Une avancée majeure pour le diagnostic et le suivi des maladies chez les équidés BioMérieux Diagnostic Tests Rapides Endocrinologie Équine Maladies Équines
REGULATED PRESS RELEASE published on 12/04/2025 at 07:01, 2 months ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health bioMérieux launches endocrinology testing offer for equine health with VIDAS® Equine ACTH and INSULIN immunoassays BioMérieux Veterinary Medicine Endocrinology Equine Health Immunoassay Tests
BRIEF published on 12/02/2025 at 15:49, 2 months 2 days ago BioMérieux: Update on the number of shares and voting rights Share Capital Voting Rights BioMérieux Actions Finance
BRIEF published on 12/02/2025 at 15:49, 2 months 2 days ago BioMérieux : Mise à jour du nombre d'actions et de droits de vote Droits De Vote Capital Social BioMérieux Actions Finance
REGULATED PRESS RELEASE published on 12/02/2025 at 15:44, 2 months 2 days ago Novembre 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant Communiqué mensuel sur le nombre de droits de vote et d'actions de la société bioMérieux. Informations conformes à la réglementation financière en vigueur Autorité Des Marchés Financiers BioMérieux Nombre De Droits De Vote Informations Mensuelles Code BIM
BRIEF published on 11/05/2025 at 07:06, 2 months 29 days ago Oxford Nanopore and bioMérieux Unveil AmPORE-TB for Drug-Resistant TB Analysis BioMérieux Tuberculosis AmPORE-TB Oxford Nanopore Sequencing Technology
BRIEF published on 11/05/2025 at 07:06, 2 months 29 days ago Oxford Nanopore et bioMérieux dévoilent une innovation pour combattre la tuberculose résistante BioMérieux Antibiorésistance Séquençage ADN AmPORE-TB Oxford Nanopore
REGULATED PRESS RELEASE published on 11/05/2025 at 07:01, 2 months 29 days ago Oxford Nanopore et bioMérieux lancent AmPORE-TB, une solution de séquençage, à usage de recherche uniquement, pour identifier rapidement la tuberculose résistante aux antibiotiques Oxford Nanopore et bioMérieux lancent AmPORE-TB, une solution de séquençage pour identifier la tuberculose résistante aux antibiotiques, recommandée par l'OMS Séquençage OMS Antibiotiques Tuberculose AmPORE-TB
REGULATED PRESS RELEASE published on 11/05/2025 at 07:01, 2 months 29 days ago Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only solution for rapid characterization of drug resistant-tuberculosis, using nanopore sequencing technology BioMérieux AmPORE-TB Oxford Nanopore Sequencing Technology Drug-resistant Tuberculosis
BRIEF published on 11/04/2025 at 11:22, 3 months ago Status of shares and voting rights at bioMérieux in October 2025 Share Capital Voting Rights Shares BioMérieux Financial Transparency
Published on 02/05/2026 at 01:35, 53 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 2 hours 28 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 4 hours 3 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 10 hours 13 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 20:54, 5 hours 34 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 5 hours 52 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 6 hours 28 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 7 hours 33 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 7 hours 48 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 8 hours 24 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 8 hours 24 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 8 hours 43 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 8 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL